Patients Are at the Forefront of Everything We Do

With a vision of creating a healthier tomorrow, we are steadfast in our approach to translating novel biologic insights into targeted therapies for patients who have few to no treatment options. 

We are driven to advance patient care with targeted, first-in-class, novel mechanism therapies that address significant unmet medical needs.

We Are Committed to Patients

All of us at Ardelyx are sincerely grateful to the patients who have participated in our clinical studies, as well as their families and caregivers who are with them along their journey. Everyone here at Ardelyx is passionately committed to serving patients in the best way possible, and it’s because of each patient’s individual contribution that we are able to do the work necessary to bring forward important new medicines.”

 

Mike Raab
President & Chief Executive Officer

Partners and Advocacy Collaborations

RSN-Logo-Web-Address